FIBROVEIN HOLDINGS LIMITED

Company number 12011917 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£1,483

Balance sheet as at 2024-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2019-05-22
Employees
0 (2024 accounts)
Registered office
C/O Fibrovein Holdings Limited, Plough Lane, Hereford, United Kingdom, HR4 0EL
Postcode
HR4 0EL
Capital
1 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-03-18
Next due by
2027-04-01
View filing history →

Nature of business (SIC)

  • 46460 Wholesale of pharmaceutical goods
  • 47749 Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) not elsewhere classified
  • 96090 Other service activities not elsewhere classified

Officers 1 current · 7 resigned

Appointed 2023-10-12

View all officers and resignations →

Group structure 1 subsidiary

Controlled by Merit Medical Systems Inc (973252-0142) — since 2019-08-01

From persons-with-significant-control filings on the public register.

Contact details

Website
fibrovein.com

Fibrovein is a detergent based sclerosant and is licensed for the treatment of varicose veins. It is a sterile aqueous injection of Sodium Tetradecyl Sulfate (STS), an anionic detergent. It has been used in the treatment of varicose veins since 1946. Fibrovein is manufactured under cGMP conditions and complies with all EU regulations. The product […]

Among its peers

Among the oldest 25%

of 33 similar companies in HR, trading since 2019

Competitors Kington

This company ranks 5 among wholesale of pharmaceutical goods in Kington.

Full league table →

The class of 2019

32%

of the 381 companies in this sector incorporated in 2019 are still active today; 61% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →